Metabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study

Background: There is a lack of biochemical markers for early prediction of relapse in patients with Graves' disease [GD], which may help to direct treatment decisions. We assessed the prognostic ability of a high-throughput proton NMR metabolomic profile to predict relapse in a well characteriz...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Endocrinol (Lausanne)
Main Authors: Struja, Tristan, Eckart, Andreas, Kutz, Alexander, Huber, Andreas, Neyer, Peter, Kraenzlin, Marius, Mueller, Beat, Meier, Christian, Bernasconi, Luca, Schuetz, Philipp
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2018
Assuntos:
Endocrinology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199355/
https://ncbi.nlm.nih.gov/pubmed/30386302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00623
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares